Best Silica Supplier: How to Choose in 2026 (Checklist and Comparison Criteria)

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silicone vs Silica: What Is the Difference and Where Is Each Used?
  • Keywords: silica particle size
  • Published: 2026-11-20 09:13:39
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
88. Ali M., Gutting B.W., Van Hoek M.L. Multiple Path Particle Dosimetry for Prediction of Mouse Lung Deposition of Nanoaerosol Particles. Int. J. Adv. Res. Eng. Technol. 2017;8:10-20. [ Google Scholar ]

INS 551 Explained: Silicon Dioxide Food Additive Code, Uses and Regulations

Silicon Dioxide Manufacturer: Production Methods, Quality Standards and Selection Tips
89. Costa A., Pinheiro M., Magalhães J., Ribeiro R., Seabra V., Reis S., Sarmento B. The formulation of nanomedicines for treating tuberculosis. Adv. Drug Deliv. Rev. 2016;102:102-115. doi: 10.1016/j.addr.2016.04.012. [ DOI ] [ PubMed ] [ Google Scholar ]
What Is Precipitated Silica? Production Process, Properties and Main Applications
Nevertheless, mesoporous carriers are frequently associated with poor tabletability because of bad powder flow behavior; thus, direct tableting can only be attained by adding diverse excipients in large quantities [ 95 ]. Such useful excipients include microcrystalline cellulose (filler), lactose monohydrate (filler), PVP (binder), sodium carboxymethylcellulose (disintegrant), croscarmellose sodium (super disintegrant), colloidal silica (anti-adhesion material), magnesium stearate (lubricant), and talc (lubricant) [ 39, 95, 96, 97 ]. However, the drug content in the dosage unit decreases with high amounts of excipients added, so larger tablets must be designed to attain the proper dose [ 95 ]. Another issue is that the greater compression force used during tableting may deform and damage the pore structure of the carrier, which might decrease the expected drug release rate [ 36, 97, 98 ]. When higher compression forces are applied, the pore diameter decreases, which affects both total pore volume and particular surface region, reducing the drug release rate from the carrier [ 97, 98 ]. The use of microcrystalline cellulose may be a solution to this problem, as it deforms plastically under pressure while distributing the energy accumulated in the tablet during compression. Furthermore, croscarmellose sodium may improve the drug release rate [ 97, 98 ]. Granulation of mesoporous material is a proper choice to solve issues related to poor powder rheology.
Silica Market Trends 2026: Demand Drivers, Technologies and Regional Outlook
Silica as an Anti-Caking Agent: Mechanism, Dosage and Applications
Several recent research works can support the prior finding and show that APIs in MSNs sustain their chemical structure, unaffected by covalent bonding during adsorption, storage, or release. Porras et al. observed consistent FTIR peaks for drug-MSN systems (albendazole loaded into SBA-15), confirming the preservation of functional groups [ 50 ]. Ditzinger et al. attained the stabilization of haloperidol and carbamazepine in their amorphous forms through adsorption into mesoporous silica, sustaining their chemical integrity [ 51 ]. PXRD and DSC analyses confirmed that the drugs remained amorphous post-incorporation without recrystallization for at a minimum three months. Particularly, the absence of new PXRD peaks and DSC melting endotherms during this period signals there is no chemical degradation or alteration of the chemical structure [ 51 ]. Minecka et al. demonstrated that while aripiprazole transforms from crystalline to amorphous form upon adsorption into mesoporous silica, the chemical structure of the API remains unchanged [ 52 ]. To track the molecular state of the drug during and after amorphization, calorimetric, X-ray diffraction, and dielectric methods were carried out by the researchers to provide proof. The findings recommend that the steric hindrance impact averts recrystallization, consequently preserving chemical structures as amorphous APIs revert to the original form [ 52 ]. Knapik-Kowalczuk et al. found that celecoxib in Syloid 244FP exhibits stable FTIR and NMR signals and intact molecular dynamics after amorphization, showing stabilization via physical interactions (steric hindrance and surface interactions without extra bond formation) [ 53 ]. Richter et al. converted itraconazole to an amorphous form in the presence of mesoporous silica, without altering its chemical structure, by the twin-screw extrusion method, as confirmed by consistent thermal and diffraction analyses [ 54 ]. Furthermore, Antonino et al. highlighted the transition of naproxen and ibuprofen from crystalline to amorphous when they were adsorbed into mesoporous silica (Syloid 72FP) [ 55 ]. This change is purely physical, with no chemical alterations to the drug molecules. Approaches such as differential scanning calorimetry (DSC), X-ray diffraction (XRPD), and solid-state NMR verify that the APIs' chemical structure of the APIs remains intact throughout and after amorphization. Drug adsorption onto the silica surface creates a stabilized amorphous state that resists recrystallization without changing the chemical bonds of the APIs. This stabilization stems from physical confinement and interactions such as hydrogen bonding or van der Waals forces with the silica, without any chemical reactions or degradation [ 55 ]. In summary, MSNs accomplish API amorphization and stabilization through steric confinement and non-covalent adsorption, thereby preserving chemical structures, as verified by consistent data obtained by researchers.

What Is Silica? Definition, Main Types, Key Properties and Industrial Uses (2026 Guide)

What is silica (SiO₂)?

silicon dioxide chemical properties In spite of the advantages of solvent-free processes, solvent-based techniques offer a more widespread choice for filling the pores of the carriers. Each method listed here consists of two steps. First, mixing the drug solution and carrier, then removing the solvent [ 36 ]. The loading cycles can be repeated as many times as desired to increase the charging efficiency [ 20, 36 ]. These techniques can be effectively applied to molecules both with great and poor aqueous solubility [ 37 ]. However, removing the solvent residue at the end of the process is essential, owing to the toxicity of usually used organic solvents [ 56 ], and it is normally better to select a less toxic organic solvent, if possible [ 37, 56 ]. The adsorption of the API is also influenced by the properties of the solvent, such as viscosity or surface tension. This group includes the adsorption approach, the incipient wetness approach, the solvent evaporation method, and the use of liquid and supercritical CO 2. The adsorption technique (solvent immersion method) is a low-energy process, but the pores can be filled effectively only if the API reaches a high concentration in the solvent [ 37 ]. The carrier system is immersed in the concentrated drug solution, while the liquid fills the pores owing to capillary forces. The mesopores are then separated from the solution by filtration or centrifugation. Finally, the pores are dried under reduced pressure [ 2, 36, 37 ]. Drug loading abilities can be seen for some APIs by this loading approach, in the following figure ( Figure 1 ). During the incipient wetness impregnation, a greatly concentrated drug solution is added dropwise onto the surface of the mesopores, in a nearly equal volume to the pore volume of the carrier [ 37 ]. In this case, the pores are filled with liquid also owing to the capillary forces. Then the pores are dried out at a higher temperature and under reduced pressure [ 2, 36, 37 ]. Nevertheless, the third approach, solvent evaporation, is the most widely used because it can be applied to a wide range of molecules, regardless of their solubility, making it fitting for higher therapeutic doses as well. It is not necessary to prepare a concentrated solution since the concentration gradually increases during the process (owing to the evaporation of the solvent). During the process, the drug should be dissolved in a volatile organic solvent, which is mixed with the carrier system [ 20 ]. All solvents are then eliminated by quick evaporation [ 37 ], while the drug is absorbed into the pores of the drug carrier [ 36, 37 ]. The use of supercritical CO 2 brings about more productive and deeper pore filling compared to other solvents. In this state, neither a liquid phase nor a gas phase exists. It combines the brilliant diffusion capacity of gases and the excellent solvation capacity of liquids. In addition, it is non-toxic, non-flammable, and can be readily eliminated from the system. A cost-effective choice can be liquid CO 2, which is a similarly effective solvent [ 36, 37 ].

What is the difference between fumed silica and precipitated silica?

silica manufacturers list

What drives silica raw material prices?

BET surface area silica

Cite this article: Silica Raw Materials News. "What Is Silica? A Simple Explanation of Silica, Its Forms and Uses ." Published 2026-11-20 09:13:39. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.